Editas Medicine EDIT Cash Flow Statement (2015-2025)

NASDAQ EDIT
$2.59 +0.08 (+3.19%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Editas Medicine Quarterly Cash Flow Statement

Periods 43 quarters
Latest Sep 2025

Editas Medicine reported cash from operations of -$30.84M and free cash flow of -$31.28M for the quarter ended Sep 2025, up 41.3% year over year. This cash flow statement covers 43 quarters of results from Mar 2015 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income
-65.64M-56.75M-55.26M-39.10M-41.44M-50.28M-53.69M-55.73M-60.73M-47.45M-40.28M-45.02M-18.86M-61.96M-67.61M-62.14M-45.39M-75.66M-51.48M-25.12M
Depreciation and DepletionDep. & Depletion
1.22M1.16M1.19M1.19M1.56M1.56M1.60M1.60M1.58M1.54M1.54M1.51M1.50M1.41M1.42M1.60M1.38M1.92M1.83M0.72M
Share-based CompensationStock Comp.
5.67M12.20M13.53M10.01M7.66M11.43M6.62M5.88M5.36M4.51M5.21M4.73M5.34M7.58M5.01M4.80M4.02M2.98M2.66M2.23M
Gains from Sales and DivestituresGains Divest
-1.58M1.58M-0.14M-0.01M
Asset Writedowns and ImpairmentWritedown
3.72M
Cash from OperationsCash from Ops.
-40.10M-49.48M-38.96M-40.78M-34.58M-49.23M-37.84M-48.00M-42.27M-35.77M-38.71M-35.46M-22.24M-49.87M-57.06M-52.59M-50.76M-47.80M-50.21M-30.84M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.22M1.16M1.19M1.19M1.56M1.56M1.60M1.60M1.58M1.54M1.54M1.51M1.50M1.41M1.42M1.60M1.38M1.92M1.83M0.72M
Change in Working Capital
Change in ReceivablesChange Receivables
4.99M-5.38M-0.34M-0.08M0.02M1.10M-0.66M-0.59M5.03M-4.90M2.04M0.14M7.76M-9.94M-0.00M-0.12M16.14M-15.76M0.08M7.54M
Change in Account PayablesChange Payables
1.30M2.02M-3.83M-1.16M1.84M-0.23M1.48M0.42M2.69M-0.56M-0.70M2.36M-2.59M-1.46M7.42M-1.25M-7.00M-0.03M1.26M-3.56M
Change in Accured ExpensesChange Accured Exp.
4.10M-9.56M3.55M-3.42M5.27M-3.98M4.38M-0.89M10.99M1.43M-3.79M2.38M4.09M-2.69M-3.84M1.01M17.15M1.69M0.58M-0.54M
Other Working Capital ChangesOther WC Changes
-5.77M-5.55M-0.15M-5.67M-11.33M-5.52M-0.60M1.04M22.65M-6.81M0.05M-2.58M1.93M-2.40M4.56M-5.47M-5.16M-4.22M-4.83M-1.48M
Investing Activities
Capital ExpendituresCapex
1.38M0.08M2.70M2.34M2.85M2.25M0.63M0.61M0.62M1.84M1.33M0.24M1.31M1.87M3.49M2.92M0.54M0.11M0.43M
Sales of Property, Plant and EquipmentPP&E (Sale)
-0.01M0.15M
Cash from Investing ActivitiesCash from Investing
-108.89M3.24M4.79M-39.66M-22.84M56.37M-4.00M89.23M-27.53M23.27M12.98M-102.82M62.84M-4.75M51.95M83.98M30.96M56.39M42.65M39.57M
Financing Activities
Cash from Financing ActivitiesCash from Financing
9.10M261.47M17.08M2.50M1.06M0.22M0.37M0.08M0.62M117.53M0.51M0.19M0.32M55.51M-1.44M7.41M17.17M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
-0.11M249.47M-0.01M0.00M0.22M0.15M0.61M0.19M0.13M0.27M1.44M7.18M17.15M
Additional items
Change in Cash
-139.89M215.24M-17.08M-77.95M-56.37M7.36M-41.48M41.30M-69.18M-12.50M91.80M-138.28M41.11M-54.42M-4.79M31.39M35.71M7.15M-0.15M25.90M
Free Cash FlowFCF
-41.48M-49.56M-41.66M-43.13M-37.43M-51.48M-38.48M-48.62M-42.90M-37.61M-40.04M-35.70M-23.55M-51.74M-60.56M-55.51M-51.30M-47.91M-50.21M-31.28M
Net Cash FlowNCF
-139.89M215.24M-17.08M-77.95M-56.37M7.36M-41.48M41.30M-69.18M-12.50M91.80M-138.28M41.11M-54.42M-4.79M31.39M35.71M7.15M-0.15M25.90M

Editas Medicine Cash Flow Statement API

Pull Editas Medicine's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EDIT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY